Aquaporin‐4 Antibody Dynamics and Relapse Risk in Seropositive Neuromyelitis Optica Spectrum Disorder Treated with Immunosuppressants
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Neurology"
DOI: 10.1002/ana.26623
Abstract: To investigate aquaporin‐4 antibody (AQP4‐IgG) dynamics and relapse risk in patients with seropositive neuromyelitis optica spectrum disorder treated with immunosuppressants. read more here.
Keywords: neuromyelitis optica; seropositive neuromyelitis; optica spectrum; aquaporin antibody ... See more keywords
Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15479
Abstract: Aquaporin‐4 IgG seropositive neuromyelitis optica spectrum disorder (AQP4‐IgG NMOSD) might occur in association with cancer. According to diagnostic criteria, a probable paraneoplastic NMOSD can be diagnosed only in patients with isolated myelitis and adenocarcinoma or… read more here.
Keywords: neuromyelitis optica; igg seropositive; seropositive neuromyelitis; aquaporin igg ... See more keywords
Epidemiology of Seropositive Neuromyelitis Optica Spectrum Disorder in a Large US Population
Sign Up to like & getrecommendations! Published in 2024 at "Neurology"
DOI: 10.1212/01.wnl.0001051708.92583.a9
Abstract: Objective To define the epidemiology and demographics of seropositive neuromyelitis optica spectrum disorder (NMOSD) in a large US health system. Background Epidemiological studies of NMOSD have been limited by several factors. Challenges include disease rarity… read more here.
Keywords: epidemiology; neuromyelitis optica; optica spectrum; population ... See more keywords